Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Avantor Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Beam Therapeutics Inc. June 3, 202690.5%
-
Kyverna Therapeutics Inc. May 27, 202699.3%
-
Avantor Inc. May 11, 202399.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | Kyverna Therapeutics Inc. | Shares withheld for tax | −4,194 | $8.59 | $36,026 |
| Jan 12, 2026 | Kyverna Therapeutics Inc. | Grant or award | +30,000 | — | — |
| Jan 12, 2026 | Kyverna Therapeutics Inc. | Grant or award | +24,301 | — | — |
| May 29, 2025 | Kyverna Therapeutics Inc. | Grant or award | +16,634 | — | — |
| May 11, 2023 | Avantor Inc. | Grant or award | +9,808 | — | — |
Questions about Christi Shaw
What boards is Christi Shaw on?
Christi Shaw sits on the boards of Avantor Inc., Beam Therapeutics Inc. and Kyverna Therapeutics Inc.
How long has Christi Shaw served on boards?
Our records show at least 9 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.